image
FONAR Corporation FONR
Healthcare - Medical - Devices - NASDAQ - US
Watchlist
$ 13.0
-2.84 %
$ 80.6 M
Market Cap
11.3
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one FONR stock under the worst case scenario is HIDDEN Compared to the current market price of 13 USD, FONAR Corporation is HIDDEN

FONR Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one FONR stock under the base case scenario is HIDDEN Compared to the current market price of 13 USD, FONAR Corporation is HIDDEN

FONR Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one FONR stock under the best case scenario is HIDDEN Compared to the current market price of 13 USD, FONAR Corporation is HIDDEN

FONR Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart FONR

image
1M -6%
6M -21%
1Y -29.0%
3Y -42%
5Y -33%
All
$16.5$16.5$16.0$16.0$15.5$15.5$15.0$15.0$14.5$14.5$14.0$14.0$13.5$13.5$13.0$13.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
103 M REVENUE
4.30%
Growth Rates
1Year 4.30%
3Years 4.59%
5Years 3.36%
7Years 4.03%
10Years 4.15%
16.5 M OPERATING INCOME
11.81%
Growth Rates
1Year 11.81%
3Years -1.11%
5Years -5.67%
7Years -2.04%
10Years 3.00%
10.6 M NET INCOME
-12.86%
Growth Rates
1Year -12.86%
3Years -8.23%
5Years -12.42%
7Years -10.89%
10Years -2.34%
14.1 M OPERATING CASH FLOW
-2.58%
Growth Rates
1Year -2.58%
3Years -9.62%
5Years -6.24%
7Years -2.48%
10Years 0.54%
-851 K INVESTING CASH FLOW
80.39%
Growth Rates
1Year 80.39%
3Years 43.90%
5Years 46.03%
7Years 20.71%
10Years -0.19%
-8.18 M FINANCING CASH FLOW
-8.04%
Growth Rates
1Year -8.04%
3Years -7.36%
5Years -4.32%
7Years 3.99%
10Years 2.41%
25 M REVENUE
-0.04%
Growth Rates
1Year 4.30%
3Years 4.59%
5Years 3.36%
7Years 4.03%
10Years 4.15%
2.44 M OPERATING INCOME
-47.13%
Growth Rates
1Year 11.81%
3Years -1.11%
5Years -5.67%
7Years -2.04%
10Years 3.00%
2.2 M NET INCOME
-44.88%
Growth Rates
1Year -12.86%
3Years -8.23%
5Years -12.42%
7Years -10.89%
10Years -2.34%
2.24 M OPERATING CASH FLOW
35.30%
Growth Rates
1Year -2.58%
3Years -9.62%
5Years -6.24%
7Years -2.48%
10Years 0.54%
-739 K INVESTING CASH FLOW
59.35%
Growth Rates
1Year 80.39%
3Years 43.90%
5Years 46.03%
7Years 20.71%
10Years -0.19%
-2.11 M FINANCING CASH FLOW
-6.34%
Growth Rates
1Year -8.04%
3Years -7.36%
5Years -4.32%
7Years 3.99%
10Years 2.41%
Balance Sheet FONAR Corporation
image
Current Assets 140 M
Cash & Short-Term Investments 56.5 M
Receivables 79.8 M
Other Current Assets 4 M
Non-Current Assets 73.9 M
Long-Term Investments 0
PP&E 57.7 M
Other Non-Current Assets 16.3 M
26.36 %37.27 %26.92 %7.59 %Total Assets$214.2m
Current Liabilities 17.9 M
Accounts Payable 1.86 M
Short-Term Debt 3.75 M
Other Current Liabilities 12.3 M
Non-Current Liabilities 39.6 M
Long-Term Debt 37.9 M
Other Non-Current Liabilities 1.67 M
3.23 %6.52 %21.33 %66.01 %2.91 %Total Liabilities$57.5m
EFFICIENCY
Earnings Waterfall FONAR Corporation
image
Revenue 103 M
Cost Of Revenue 57.7 M
Gross Profit 45.1 M
Operating Expenses 28.6 M
Operating Income 16.5 M
Other Expenses 5.97 M
Net Income 10.6 M
120m120m100m100m80m80m60m60m40m40m20m20m00103m(58m)45m(29m)17m(6m)11mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
43.87% GROSS MARGIN
43.87%
Averages
1Year 43.87%
3Years 46.14%
5Years 47.25%
7Years 47.76%
10Years 47.70%
16.07% OPERATING MARGIN
16.07%
Averages
1Year 16.07%
3Years 17.87%
5Years 16.58%
7Years 18.92%
10Years 19.52%
10.27% NET MARGIN
10.27%
Averages
1Year 10.27%
3Years 12.48%
5Years 13.26%
7Years 16.55%
10Years 18.11%
6.37% ROE
6.37%
Averages
1Year 6.37%
3Years 7.92%
5Years 8.59%
7Years 11.73%
10Years 17.11%
4.93% ROA
4.93%
Averages
1Year 4.93%
3Years 6.08%
5Years 6.39%
7Years 9.32%
10Years 12.05%
6.05% ROIC
6.05%
Averages
1Year 6.05%
3Years 6.89%
5Years 6.49%
7Years 10.63%
10Years 15.71%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis FONAR Corporation
image
16m16m14m14m12m12m10m10m8m8m6m6m4m4m2m2m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 10.6 M
Depreciation & Amortization 8.91 M
Capital Expenditures -823 K
Stock-Based Compensation 0
Change in Working Capital -12.9 M
Others 3.37 M
Free Cash Flow 13.3 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets FONAR Corporation
image
FONR has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 8
6. Ownership
Insider Ownership FONAR Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
FONR Stock Declines After Q2 Earnings, Revenue and Net Income Fall FONAR's second-quarter fiscal 2025 revenues and net income decline. Higher costs and lower scan volumes weigh on results. zacks.com - 1 month ago
Fonar Announces Six Month and 2nd Quarter Financial Results for Fiscal 2025 MRI scan volume at HMCA managed sites increased 7% to 79,207 scans during the six-month period ended December 31, 2024, versus 73,776 scans for the six-month period ended December 31, 2023. MRI scan volume at HMCA owned sites decreased 4% to 26,961 scans during the six-month period ended December 31, 2024, versus 28,214 scans for the six-month period ended December 31, 2023. newsfilecorp.com - 2 months ago
FONAR: Assets Remain Too Cheap To Pass Up Despite recent underperformance, FONAR remains a value play with minimal debt, positive profitability, and attractive valuation multiples, particularly a P/B ratio of 0.61. Q1-Fiscal 2025 earnings showed a decline, but FONAR's book value continues to grow, driven by strategic investments in high-field MRI scanners and new locations. Risks include market punishment for near-term growth rates and low trading volume, but downside risk is limited due to strong financials and shareholder-friendly trends. seekingalpha.com - 4 months ago
FONR Stock Gains Despite Q1 Earnings Dip and Rising Expenses FONAR's fiscal first-quarter earnings reveals a decline in revenues and income, driven by decreased patient fees and rising costs, while MRI scan volume sees modest growth. zacks.com - 5 months ago
Fonar Announces Financial Results for the 1st Quarter of Fiscal 2025 Total MRI scan volume at the HMCA-managed sites increased 5% to 53,054 scans for the quarter ending September 30, 2024 versus the corresponding quarter one year earlier. Cash and cash equivalents decreased 4% to $54.2 million at September 30, 2024 as compared to the fiscal year-ended June 30, 2024. newsfilecorp.com - 5 months ago
FONR's Stock Down Despite Earnings, Revenues Uptick in Fiscal 2024 Strength in FONAR's HMCA segment's revenues drives its top line in fiscal 2024. zacks.com - 6 months ago
Fonar Announces Fiscal 2024 Financial Results Total MRI scan volume at the HMCA-managed sites increased 11% to 209,327 scans for the fiscal year ending June 30, 2024 as compared to the prior year. Cash and Cash Equivalents increased 10% to $56.3 million at June 30, 2024 versus the previous fiscal year. newsfilecorp.com - 6 months ago
FONAR Corporation: Shares Look Ready To Embark On A Sustained Bullish Run (Technical Analysis) FONAR Corporation showed encouraging growth trends in revenues and earnings, leading to a 'Buy' rating last year. Recent technical trends suggest a potential long-term change in the stock trend, supported by strong near-term growth rates and a favorable valuation. Forward-looking fundamentals, including the adoption of SwiftMR, indicate potential for continued growth and profitability for FONR shareholders. seekingalpha.com - 9 months ago
Zacks Initiates Coverage of FONAR Corporation With Outperform Recommendation Discover why Zacks rates FONAR Corporation as "Outperform", being the first on Wall Street to initiate coverage on the stock. Explore FONR's strategic expansion, financial health and market positioning for growth in the MRI diagnostic services space. zacks.com - 10 months ago
Fonar Announces Fiscal 2024 Financial Results for 3rd Quarter and Nine-Month Period Total MRI scan volume at the HMCA-managed sites increased 11% to 154,790 scans for the nine-month period ended March 31, 2024 as compared to the nine-month period ended March 31, 2023. Net Income increased 25% to $12.5 million for the nine-month period ended March 31, 2024 as compared to the nine-month period ended March 31, 2023. newsfilecorp.com - 11 months ago
FONAR: Recent Selloff Seems Unjustified As EV/EBITDA Approaches 4x The company focuses on managing diagnostic imaging centers, and it has slow and predicable revenue growth with decent margins. In my view, the Q2 FY24 results were strong as revenues inched up by 4.7% to $25.4 million while attributable net income soared by 68.4% to $3.8 million. The market capitalization of Fonar slumped by over 20% in the past month, and I think this creates a good buying opportunity here. seekingalpha.com - 1 year ago
Fonar Announces Six Months and 2nd Quarter Financial Results for Fiscal 2024 Total MRI scan volume at the HMCA-managed sites increased 13% to 101,990 scans for the six months ending December 31, 2023 versus the corresponding period one year earlier. Cash and cash equivalents and short-term investments increased 4% to $53.2 million at December 31, 2023, versus the fiscal year ended June 30, 2023. newsfilecorp.com - 1 year ago
8. Profile Summary

FONAR Corporation FONR

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 80.6 M
Dividend Yield 0.00%
Description FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
Contact 110 Marcus Drive, Melville, NY, 11747 https://www.fonar.com
IPO Date Oct. 29, 1981
Employees 520
Officers Mr. Daniel Culver Director of Communications Ms. Claudette J. V. Chan Secretary & Director Mr. Luciano B. Bonanni Chief Operating Officer, Executive Vice President & Acting Principal Financial Officer Mr. Timothy R. Damadian M.D. Chairman, President, Chief Executive Officer & Treasurer